Cande V Ananth1,2, Robert L Goldenberg1, Alexander M Friedman1, Anthony M Vintzileos3. 1. Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York. 2. Department of Health Policy and Management, Joseph L. Mailman School of Public Health, Columbia University, New York, New York. 3. Department of Obstetrics and Gynecology, New York University-Winthrop University Hospital, Mineola.
Abstract
Importance: Whether the changing gestational age distribution in the United States since 2005 has affected perinatal mortality remains unknown. Objective: To examine changes in gestational age distribution and gestational age-specific perinatal mortality. Design, Setting, and Participants: This retrospective cohort study examined trends in US perinatal mortality by linking live birth and infant death data among more than 35 million singleton births from January 1, 2007, through December 31, 2015. Exposures: Year of birth and changes in gestational age distribution. Main Outcomes and Measures: Changes in the proportion of births at gestational ages 20 to 27, 28 to 31, 32 to 33, 34 to 36, 37 to 38, 39 to 40, 41, and 42 to 44 weeks; changes in perinatal mortality (stillbirth at ≥20 weeks, and neonatal deaths at <28 days) rates; and contribution of gestational age changes to perinatal mortality. Trends were estimated from log-linear regression models adjusted for confounders. Results: Among the 34 236 577 singleton live births during the study period, the proportion of births at all gestational ages declined, except at 39 to 40 weeks, which increased (54.5% in 2007 to 60.2% in 2015). Overall perinatal mortality declined from 9.0 to 8.6 per 1000 births (P < .001). Stillbirths declined from 5.7 to 5.6 per 1000 births (P < .001), and neonatal mortality declined from 3.3 to 3.0 per 1000 births (P < .001). Although the proportion of births at gestational ages 34 to 36, 37 to 38, and 42 to 44 weeks declined, perinatal mortality rates at these gestational ages showed annual adjusted relative increases of 1.0% (95% CI, 0.6%-1.4%), 2.3% (95% CI, 1.9%-2.8%), and 4.2% (95% CI, 1.5%-7.0%), respectively. Neonatal mortality rates at gestational ages 34 to 36 and 37 to 38 weeks showed a relative adjusted annual increase of 0.9% (95% CI, 0.2%-1.6%) and 3.1% (95% CI, 2.1%-4.1%), respectively. Although the proportion of births at gestational age 39 to 40 weeks increased, perinatal mortality showed an annual relative adjusted decline of -1.3% (95% CI, -1.8% to -0.9%). The decline in neonatal mortality rate was largely attributable to changes in the gestational age distribution than to gestational age-specific mortality. Conclusions and Relevance: Although the proportion of births at gestational age 39 to 40 weeks increased, perinatal mortality at this gestational age declined. This finding may be owing to pregnancies delivered at 39 to 40 weeks that previously would have been unnecessarily delivered earlier, leaving fetuses at higher risk for mortality at other gestational ages.
Importance: Whether the changing gestational age distribution in the United States since 2005 has affected perinatal mortality remains unknown. Objective: To examine changes in gestational age distribution and gestational age-specific perinatal mortality. Design, Setting, and Participants: This retrospective cohort study examined trends in US perinatal mortality by linking live birth and infantdeath data among more than 35 million singleton births from January 1, 2007, through December 31, 2015. Exposures: Year of birth and changes in gestational age distribution. Main Outcomes and Measures: Changes in the proportion of births at gestational ages 20 to 27, 28 to 31, 32 to 33, 34 to 36, 37 to 38, 39 to 40, 41, and 42 to 44 weeks; changes in perinatal mortality (stillbirth at ≥20 weeks, and neonatal deaths at <28 days) rates; and contribution of gestational age changes to perinatal mortality. Trends were estimated from log-linear regression models adjusted for confounders. Results: Among the 34 236 577 singleton live births during the study period, the proportion of births at all gestational ages declined, except at 39 to 40 weeks, which increased (54.5% in 2007 to 60.2% in 2015). Overall perinatal mortality declined from 9.0 to 8.6 per 1000 births (P < .001). Stillbirths declined from 5.7 to 5.6 per 1000 births (P < .001), and neonatal mortality declined from 3.3 to 3.0 per 1000 births (P < .001). Although the proportion of births at gestational ages 34 to 36, 37 to 38, and 42 to 44 weeks declined, perinatal mortality rates at these gestational ages showed annual adjusted relative increases of 1.0% (95% CI, 0.6%-1.4%), 2.3% (95% CI, 1.9%-2.8%), and 4.2% (95% CI, 1.5%-7.0%), respectively. Neonatal mortality rates at gestational ages 34 to 36 and 37 to 38 weeks showed a relative adjusted annual increase of 0.9% (95% CI, 0.2%-1.6%) and 3.1% (95% CI, 2.1%-4.1%), respectively. Although the proportion of births at gestational age 39 to 40 weeks increased, perinatal mortality showed an annual relative adjusted decline of -1.3% (95% CI, -1.8% to -0.9%). The decline in neonatal mortality rate was largely attributable to changes in the gestational age distribution than to gestational age-specific mortality. Conclusions and Relevance: Although the proportion of births at gestational age 39 to 40 weeks increased, perinatal mortality at this gestational age declined. This finding may be owing to pregnancies delivered at 39 to 40 weeks that previously would have been unnecessarily delivered earlier, leaving fetuses at higher risk for mortality at other gestational ages.
Authors: Elizabeth A Howell; Teresa Janevic; Paul L Hebert; Natalia N Egorova; Amy Balbierz; Jennifer Zeitlin Journal: JAMA Pediatr Date: 2018-03-01 Impact factor: 16.193
Authors: Hannah H Chang; Jim Larson; Hannah Blencowe; Catherine Y Spong; Christopher P Howson; Sarah Cairns-Smith; Eve M Lackritz; Shoo K Lee; Elizabeth Mason; Andrew C Serazin; Salimah Walani; Joe Leigh Simpson; Joy E Lawn Journal: Lancet Date: 2012-11-16 Impact factor: 79.321
Authors: Jennifer L Richards; Michael S Kramer; Paromita Deb-Rinker; Jocelyn Rouleau; Laust Mortensen; Mika Gissler; Nils-Halvdan Morken; Rolv Skjærven; Sven Cnattingius; Stefan Johansson; Marie Delnord; Siobhan M Dolan; Naho Morisaki; Suzanne Tough; Jennifer Zeitlin; Michael R Kramer Journal: JAMA Date: 2016-07-26 Impact factor: 56.272
Authors: William M Callaghan; Marian F MacDorman; Carrie K Shapiro-Mendoza; Wanda D Barfield Journal: Am J Obstet Gynecol Date: 2016-09-28 Impact factor: 8.661
Authors: Elaine M Boyle; Gry Poulsen; David J Field; Jennifer J Kurinczuk; Dieter Wolke; Zarko Alfirevic; Maria A Quigley Journal: BMJ Date: 2012-03-01
Authors: Cande V Ananth; Alexander M Friedman; Robert L Goldenberg; Jason D Wright; Anthony M Vintzileos Journal: JAMA Pediatr Date: 2018-10-01 Impact factor: 16.193
Authors: Galit Levi Dunietz; Kerby Shedden; Enrique F Schisterman; Lynda D Lisabeth; Marjorie C Treadwell; Louise M O'Brien Journal: Paediatr Perinat Epidemiol Date: 2018-09-28 Impact factor: 3.980
Authors: Jessica K Sexton; Michael Coory; Sailesh Kumar; Gordon Smith; Adrienne Gordon; Georgina Chambers; Gavin Pereira; Camille Raynes-Greenow; Lisa Hilder; Philippa Middleton; Anneka Bowman; Scott N Lieske; Kara Warrilow; Jonathan Morris; David Ellwood; Vicki Flenady Journal: Diagn Progn Res Date: 2020-12-16